Fibrin-associated diffuse large B-cell lymphoma in an ovarian endometriotic cyst: a case report and review of the literature

In: Journal of Medical Case Reports · 2026 · doi:10.1186/s13256-026-06623-6 · W7223129725
Case report OA: gold CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-25 ⓘ

This case report describes the first documented occurrence of fibrin-associated diffuse large B-cell lymphoma arising within an ovarian endometriotic cyst, highlighting the potential for multiple neoplastic processes to coexist in endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-25 · read from full text ⓘ

This case report describes the first documented instance of fibrin-associated diffuse large B-cell lymphoma (FA-DLBCL) developing within an ovarian endometriotic cyst in a 59-year-old woman with a history of endometriosis. The authors highlight that the chronic inflammation and fibrin accumulation characteristic of endometriotic cysts create a permissive microenvironment for Epstein-Barr virus-driven lymphomagenesis, although the patient ultimately succumbed to metastatic clear cell carcinoma rather than recurrent lymphoma. This finding expands the known spectrum of precursor lesions for FA-DLBCL to include endometriotic cysts, underscoring the need for comprehensive histopathological evaluation in such cases. Relevance to endometriosis: Centrally about the condition, as it reports the first case of a specific lymphoma arising within an ovarian endometriotic cyst and discusses the pathophysiological link between endometriosis-associated inflammation and EBV-positive lymphoma development.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Fibrin-associated diffuse large B-cell lymphoma (FA-DLBCL) is a rare, Epstein–Barr virus (EBV)-positive lymphoma typically occurring in immune-privileged, fibrin-rich environments. It shows an indolent course and is often incidental. While previously reported in thrombi, hematomas, and implants, no cases have been linked to endometriosis. We report the first documented case of FA-DLBCL arising in an ovarian endometriotic cyst. Case presentation A 59-year-old Asian woman with a history of endometriosis presented with progressive abdominal distension. Imaging revealed large cystic ovarian tumors, and bilateral adnexectomy was performed. Intraoperative findings included a 26-cm right ovarian mass comprising two tumors and a 13-cm left ovarian cyst. Histopathology of one right ovarian tumor revealed FA-DLBCL within a fibrin-rich, endometriotic cyst, confirmed by a cluster of differentiation (CD)20, CD30, and Epstein–Barr virus-encoded small RNA in situ hybridization (EBER-ISH) positivity. Serum EBV tests suggested prior infection. The patient remained recurrence-free for 2 years but subsequently developed a pelvic mass with markedly elevated CA 125 levels. Surgical resection revealed metastatic clear cell carcinoma without evidence of recurrent FA-DLBCL, and the patient was diagnosed with stage IIIA1(II) ovarian cancer. This is the first reported case of FA-DLBCL arising within an ovarian endometriotic cyst. FA-DLBCL typically develops in immune-privileged, fibrin-rich, and chronically inflamed environments. Endometriotic cysts share similar characteristics, including hemorrhage, chronic inflammation, and fibrin accumulation, suggesting a permissive microenvironment for EBV-driven lymphomagenesis. In this case, the tumor cells were sparsely distributed within fibrin and difficult to identify, underscoring the diagnostic challenge. Immunohistochemical screening, particularly with CD30 and EBER-ISH, was crucial for diagnosis. The FA-DLBCL component showed no recurrence after surgery; however, the patient later developed ovarian clear cell carcinoma, a known malignancy associated with endometriosis, and died despite treatment. This case underscores the importance of comprehensive histopathological evaluation and vigilant long-term follow-up in patients with endometriotic cysts, as multiple neoplastic processes, including lymphoma and carcinoma, may coexist and influence prognosis. It expands the spectrum of precursor lesions for FA-DLBCL to include endometriotic cysts.
Full text 5,672 characters · extracted from oa-html · 3 sections · click to expand

Abstract

Background Fibrin-associated diffuse large B-cell lymphoma (FA-DLBCL) is a rare, Epstein–Barr virus (EBV)-positive lymphoma typically occurring in immune-privileged, fibrin-rich environments. It shows an indolent course and is often incidental. While previously reported in thrombi, hematomas, and implants, no cases have been linked to endometriosis. We report the first documented case of FA-DLBCL arising in an ovarian endometriotic cyst. Case presentation A 59-year-old Asian woman with a history of endometriosis presented with progressive abdominal distension. Imaging revealed large cystic ovarian tumors, and bilateral adnexectomy was performed. Intraoperative findings included a 26-cm right ovarian mass comprising two tumors and a 13-cm left ovarian cyst. Histopathology of one right ovarian tumor revealed FA-DLBCL within a fibrin-rich, endometriotic cyst, confirmed by a cluster of differentiation (CD)20, CD30, and Epstein–Barr virus-encoded small RNA in situ hybridization (EBER-ISH) positivity. Serum EBV tests suggested prior infection. The patient remained recurrence-free for 2 years but subsequently developed a pelvic mass with markedly elevated CA 125 levels. Surgical resection revealed metastatic clear cell carcinoma without evidence of recurrent FA-DLBCL, and the patient was diagnosed with stage IIIA1(II) ovarian cancer.

Discussion

and conclusions This is the first reported case of FA-DLBCL arising within an ovarian endometriotic cyst. FA-DLBCL typically develops in immune-privileged, fibrin-rich, and chronically inflamed environments. Endometriotic cysts share similar characteristics, including hemorrhage, chronic inflammation, and fibrin accumulation, suggesting a permissive microenvironment for EBV-driven lymphomagenesis. In this case, the tumor cells were sparsely distributed within fibrin and difficult to identify, underscoring the diagnostic challenge. Immunohistochemical screening, particularly with CD30 and EBER-ISH, was crucial for diagnosis. The FA-DLBCL component showed no recurrence after surgery; however, the patient later developed ovarian clear cell carcinoma, a known malignancy associated with endometriosis, and died despite treatment. This case underscores the importance of comprehensive histopathological evaluation and vigilant long-term follow-up in patients with endometriotic cysts, as multiple neoplastic processes, including lymphoma and carcinoma, may coexist and influence prognosis. It expands the spectrum of precursor lesions for FA-DLBCL to include endometriotic cysts. Similar content being viewed by others Abbreviations - CA 125: - Cancer antigen 125 - CA 19-9: - Carbohydrate antigen 19-9 - CD: - Cluster of differentiation - CT: - Computed tomography - EBV: - Epstein–Barr virus - EBER-ISH: - Epstein–Barr virus-encoded small RNA in situ hybridization - EC: - Ethics committee - FA-DLBCL: - Fibrin-associated diffuse large B-cell lymphoma - Ig: - Immunoglobulin - VCA: - Virus capsid antigen

Acknowledgements

We would like to thank Ms. Naoko Tomita for her administrative assistance. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Author information Authors and Affiliations Corresponding author Ethics declarations Ethics approval and consent to participate This case report was approved by the Ethics Committee (EC) of Nihon University on August 25, 2017, with the EC approval number: RK-170711-6. It was conducted in accordance with the principles of the Declaration of Helsinki and CARE reporting guidelines. Written informed consent was obtained from the patient for participation in the study and for the publication of her de-identified data and images. Consent for publication Written informed consent was obtained from the patient during her lifetime for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests The authors declare that they have no competing interests. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. About this article Cite this article Kamata, S., Nishimaki-Watanabe, H., Yamaguchi, H. et al. Fibrin-associated diffuse large B-cell lymphoma in an ovarian endometriotic cyst: a case report and review of the literature. J Med Case Reports (2026). https://doi.org/10.1186/s13256-026-06623-6 Received: Accepted: Published: DOI: https://doi.org/10.1186/s13256-026-06623-6

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-10-31T06:00:52.059595+00:00
License: CC0 · commercial use OK